Cobblestone Capital Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Cobblestone Capital Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,391	Closed	-$379K	–	254
2020 Q3	$379K	Hold	1,391	–	–	0.03%	177
2020 Q2	$404K	Buy	1,391 +70	+5%	+$19K	0.04%	175
2020 Q1	$314K	Hold	1,321	–	–	0.03%	194
2019 Q4	$289K	Hold	1,321	–	–	0.03%	214
2019 Q3	$224K	Buy	1,321 +16	+1%	+$2.83K	0.02%	220
2019 Q2	$239K	Hold	1,305	–	–	0.02%	216
2019 Q1	$240K	Hold	1,305	–	–	0.02%	213
2018 Q4	$216K	Sell	1,305 -20	-2%	-$3.46K	0.02%	222
2018 Q3	$255K	Buy	1,325 +20	+2%	+$3.56K	0.02%	213
2018 Q2	$222K	Buy	1,305 +5	+0.4%	+$775	0.02%	226
2018 Q1	$212K	Buy	+1,300	New	+$212K	0.02%	223

Other funds holding VRTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cobblestone Capital Advisors's VRTX Position: Q4 2020 in Review

Cobblestone Capital Advisors sold out of Vertex Pharmaceuticals (VRTX) in Q4 2020, closing a stake of 1,391 shares — an estimated $379K sold.

Cobblestone Capital Advisors first reported a position in VRTX in Q1 2018 and held it in 11 quarters. The position peaked at $404K in Q2 2020. 970 funds tracked by Wall St. Rank hold VRTX as of Q4 2020.

Cobblestone Capital Advisors reported no remaining Vertex Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
Cobblestone Capital Advisors sold 1,391 Vertex Pharmaceuticals shares in Q4 2020, an estimated $379K.
Cobblestone Capital Advisors first reported a position in Vertex Pharmaceuticals in Q1 2018 and held it in 11 quarters.
Cobblestone Capital Advisors's Vertex Pharmaceuticals position peaked at $404K in Q2 2020.
970 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2020.

Based on Cobblestone Capital Advisors's 13F filing for Q4 2020, filed 9 Feb 2021.